Business Description
ORIC Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US68622P1093
Description
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 87.27 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 1.1 | |||||
| 3-Year EPS without NRI Growth Rate | 4.2 | |||||
| 3-Year FCF Growth Rate | 7 | |||||
| 3-Year Book Growth Rate | -19.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.52 | |||||
| 9-Day RSI | 61.1 | |||||
| 14-Day RSI | 56.83 | |||||
| 6-1 Month Momentum % | -4.68 | |||||
| 12-1 Month Momentum % | 10.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.15 | |||||
| Quick Ratio | 13.15 | |||||
| Cash Ratio | 12.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.4 | |||||
| Shareholder Yield % | -18.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -43.54 | |||||
| ROA % | -39.74 | |||||
| ROIC % | -331.1 | |||||
| ROC (Joel Greenblatt) % | -4585.31 | |||||
| ROCE % | -47.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.57 | |||||
| Price-to-Tangible-Book | 2.57 | |||||
| EV-to-EBIT | -3.13 | |||||
| EV-to-EBITDA | -3.16 | |||||
| EV-to-FCF | -3.84 | |||||
| Price-to-Net-Current-Asset-Value | 2.8 | |||||
| Price-to-Net-Cash | 2.88 | |||||
| Earnings Yield (Greenblatt) % | -31.95 | |||||
| FCF Yield % | -15.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ORIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ORIC Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.81 | ||
| Beta | 1.01 | ||
| Volatility % | 82.43 | ||
| 14-Day RSI | 56.83 | ||
| 14-Day ATR ($) | 0.664883 | ||
| 20-Day SMA ($) | 9.558 | ||
| 12-1 Month Momentum % | 10.58 | ||
| 52-Week Range ($) | 6.33 - 16.65 | ||
| Shares Outstanding (Mil) | 70.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ORIC Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ORIC Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ORIC Pharmaceuticals Inc Frequently Asked Questions
What is ORIC Pharmaceuticals Inc(ORIC)'s stock price today?
The current price of ORIC is $9.97. The 52 week high of ORIC is $16.65 and 52 week low is $6.33.
When is next earnings date of ORIC Pharmaceuticals Inc(ORIC)?
The next earnings date of ORIC Pharmaceuticals Inc(ORIC) is 2025-03-11 Est..
Does ORIC Pharmaceuticals Inc(ORIC) pay dividends? If so, how much?
ORIC Pharmaceuticals Inc(ORIC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers